Alvar Grönberg

Treatment with <scp>LL</scp>‐37 is safe and effective in enhancing healing of hard‐to‐heal venous leg ulcers: a randomized, placebo‐controlled clinical trial

Alvar Grönberg, Margit Mahlapuu, Mona Ståhle et al. · Wound Repair and Regeneration · 2014 · 181 citations

Venous Disease, Venous Disease Treatment, Chronic Leg Ulcers +12

Dextran sulfate sodium (DSS) induced experimental colitis in immunodeficient mice: Effects in CD4+-cell depleted, athymic and NK-cell depleted SCID mice

L.‐G. Axelsson, E. Landström, Tom J. Goldschmidt et al. · Inflammation Research · 1996 · 177 citations

Inflammation, Autoimmune Disease, Allergy +9

YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.

Gerald E. Piontek, K. Taniguchi, Hans‐Gustaf Ljunggren et al. · The Journal of Immunology · 1985 · 168 citations

Histocompatibility, Adaptive Immune System, Immunology +19

Expression of interferon-gamma (IFN-δ), IL-10, IL-12 and transforming growth factor-beta (TGF-β) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA)

Anders Bucht, Per Larsson, Lisa M. Weisbrot et al. · Clinical & Experimental Immunology · 1996 · 126 citations · Full text

Synovial Fluid Cells, Late Phases, Immunology +21

RETRACTED ARTICLE:Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor

Ada Girnita, Huiyuan Zheng, Alvar Grönberg et al. · Oncogene · 2011 · 84 citations · Full text

Immunology, Cell Death, Pathology +24